$15.500
-0.099 (-0.64%)Zum Schluss
Profitabilität und Margen von REPL
Evaluating the bottom line, Replimune Group, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -134.29%, provide a clear picture of how effectively REPL converts its operational activities into shareholder value.
REPL im Vergleich zur Peergroup
In the context of the broader market, REPL competes directly with industry leaders such as KMDA and TYRA. With a market capitalization of $1.41B, it holds a significant position in the sector. When comparing efficiency, REPL's gross margin of N/A stands against KMDA's 40.91% and TYRA's N/A. Such benchmarking helps identify whether Replimune Group, Inc. is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Replimune Group Inc
Replimune has shown strong stock performance with a year-to-date change of +74.16% and a one-year change of +162.71%. However, the company has been consistently reporting net losses, with the latest quarter showing a net income of -83,193,000 USD and an EPS of -0.77.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.